Halozyme Therapeutics
HALO
#2394
Rank
โ‚ฌ5.81 B
Marketcap
45,67ย โ‚ฌ
Share price
0.81%
Change (1 day)
34.75%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): 1,65ย โ‚ฌ

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is 1,67ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,42ย โ‚ฌ a decrease over its 2021 EPS that were of 2,74ย โ‚ฌ.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,65ย โ‚ฌ15.99%
20221,42ย โ‚ฌ-48.07%
20212,74ย โ‚ฌ196.88%
20200,92ย โ‚ฌ-292%
2019-0,48ย โ‚ฌ-9.09%
2018-0,53ย โ‚ฌ-237.5%
20170,38ย โ‚ฌ-149.38%
2016-0,78ย โ‚ฌ211.54%
2015-0,25ย โ‚ฌ-52.73%
2014-0,53ย โ‚ฌ-24.66%
2013-0,70ย โ‚ฌ48.98%
2012-0,47ย โ‚ฌ145%
2011-0,19ย โ‚ฌ-64.29%
2010-0,54ย โ‚ฌ-17.65%
2009-0,65ย โ‚ฌ9.68%
2008-0,60ย โ‚ฌ93.75%
2007-0,31ย โ‚ฌ33.33%
2006-0,23ย โ‚ฌ-4%
2005-0,24ย โ‚ฌ-3.85%
2004-0,25ย โ‚ฌ-13.33%
2003-0,29ย โ‚ฌ83.59%
2002-0,16ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,18ย โ‚ฌ-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
5,22ย โ‚ฌ 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
4,92ย โ‚ฌ 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
1,79ย โ‚ฌ 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
3,05ย โ‚ฌ 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
13,53ย โ‚ฌ 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA